SI1937245T1 - Spojina uporabna za preprečevanje in zdravljenjeleve ventrikularne hipertofije pri dializiranih pacientih - Google Patents
Spojina uporabna za preprečevanje in zdravljenjeleve ventrikularne hipertofije pri dializiranih pacientihInfo
- Publication number
- SI1937245T1 SI1937245T1 SI200631051T SI200631051T SI1937245T1 SI 1937245 T1 SI1937245 T1 SI 1937245T1 SI 200631051 T SI200631051 T SI 200631051T SI 200631051 T SI200631051 T SI 200631051T SI 1937245 T1 SI1937245 T1 SI 1937245T1
- Authority
- SI
- Slovenia
- Prior art keywords
- prevention
- treatment
- left ventricular
- ventricular hypertrophy
- compound useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Road Signs Or Road Markings (AREA)
- Finger-Pressure Massage (AREA)
- Professional, Industrial, Or Sporting Protective Garments (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/250,634 US20070087975A1 (en) | 2005-10-17 | 2005-10-17 | Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| PCT/EP2006/067465 WO2007045639A1 (en) | 2005-10-17 | 2006-10-16 | Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| EP06807318A EP1937245B1 (en) | 2005-10-17 | 2006-10-16 | Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1937245T1 true SI1937245T1 (sl) | 2011-11-30 |
Family
ID=37661169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200631051T SI1937245T1 (sl) | 2005-10-17 | 2006-10-16 | Spojina uporabna za preprečevanje in zdravljenjeleve ventrikularne hipertofije pri dializiranih pacientih |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20070087975A1 (sl) |
| EP (1) | EP1937245B1 (sl) |
| JP (1) | JP5106403B2 (sl) |
| AT (1) | ATE506946T1 (sl) |
| CY (1) | CY1112144T1 (sl) |
| DE (1) | DE602006021594D1 (sl) |
| DK (1) | DK1937245T3 (sl) |
| ES (1) | ES2364189T3 (sl) |
| PL (1) | PL1937245T3 (sl) |
| PT (1) | PT1937245E (sl) |
| SI (1) | SI1937245T1 (sl) |
| WO (1) | WO2007045639A1 (sl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101209975B (zh) * | 2006-12-29 | 2010-12-01 | 沈阳科硕营养科技有限公司 | 左旋肉碱富马酸钙及其制备方法与用途 |
| EP2353596A1 (en) | 2010-02-02 | 2011-08-10 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1156741B (it) * | 1978-05-15 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi |
| IT1156852B (it) * | 1978-07-10 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Procedimento industriale per la preparazione del d'canforato della l carnitinammide e del d canforato della d carnitinammide e sue applicazioni |
| US4434816A (en) * | 1978-10-30 | 1984-03-06 | Giovanni Bernard A Di | Service line interior by-pass fitting |
| US4968719A (en) * | 1989-04-03 | 1990-11-06 | Sigma Tau, Industrie Farmaceutiche Riunite Spa | Method for treating vascular disease |
| IT1277147B1 (it) * | 1995-01-20 | 1997-11-04 | Sigma Tau Ind Farmaceuti | Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi. |
| IT1290801B1 (it) * | 1996-07-05 | 1998-12-11 | Mendes Srl | Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili |
| IT1294227B1 (it) * | 1997-08-01 | 1999-03-24 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione |
| SK288072B6 (sk) * | 1999-10-11 | 2013-05-03 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use |
| FR2846886A1 (fr) * | 2002-11-08 | 2004-05-14 | Merck Sante Sas | Utilisation de fosinopril pour diminuer les evenements cardiovasculaires chez des patients dialyses |
-
2005
- 2005-10-17 US US11/250,634 patent/US20070087975A1/en not_active Abandoned
-
2006
- 2006-10-16 AT AT06807318T patent/ATE506946T1/de active
- 2006-10-16 SI SI200631051T patent/SI1937245T1/sl unknown
- 2006-10-16 ES ES06807318T patent/ES2364189T3/es active Active
- 2006-10-16 EP EP06807318A patent/EP1937245B1/en not_active Not-in-force
- 2006-10-16 PL PL06807318T patent/PL1937245T3/pl unknown
- 2006-10-16 DK DK06807318.8T patent/DK1937245T3/da active
- 2006-10-16 WO PCT/EP2006/067465 patent/WO2007045639A1/en active Application Filing
- 2006-10-16 PT PT06807318T patent/PT1937245E/pt unknown
- 2006-10-16 JP JP2008536039A patent/JP5106403B2/ja not_active Expired - Fee Related
- 2006-10-16 DE DE602006021594T patent/DE602006021594D1/de active Active
- 2006-10-16 US US12/066,032 patent/US20080234373A1/en not_active Abandoned
-
2011
- 2011-07-13 CY CY20111100677T patent/CY1112144T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1112144T1 (el) | 2015-11-04 |
| JP2009511619A (ja) | 2009-03-19 |
| EP1937245A1 (en) | 2008-07-02 |
| DK1937245T3 (da) | 2011-08-08 |
| ATE506946T1 (de) | 2011-05-15 |
| WO2007045639A1 (en) | 2007-04-26 |
| PT1937245E (pt) | 2011-07-06 |
| JP5106403B2 (ja) | 2012-12-26 |
| US20080234373A1 (en) | 2008-09-25 |
| WO2007045639A8 (en) | 2007-06-14 |
| PL1937245T3 (pl) | 2011-09-30 |
| DE602006021594D1 (de) | 2011-06-09 |
| US20070087975A1 (en) | 2007-04-19 |
| EP1937245B1 (en) | 2011-04-27 |
| ES2364189T3 (es) | 2011-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY148723A (en) | Use of pinolenic acid for the treatment of obesity | |
| MY145590A (en) | Phenylacetamides and their use as glucokinase modulators | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| MY148108A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
| NZ593199A (en) | Milnacipran for the long-term treatment of fybromyalgia syndrome | |
| SI1909843T1 (sl) | Protitumorski biokonjugati hialuronske kisline ali njenih derivatov, dobljeni z indirektno kemijsko konjugacijo, in njihova uporaba na farmacevtskem področju | |
| IL186544A (en) | Use of Acid 3,1 - Propandysulfonic or Sodium Salt in the Preparation of Pharmaceuticals for the Treatment of aa Amyloidosis and Pharmaceuticals for the Treatment of aa Amyloidosis | |
| TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
| CY1110182T1 (el) | Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων | |
| UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
| HK1078460A1 (en) | Use of l-carnitine, actyl l-carnitine and propionyl l-carnitine in the manufacture of a combined medicament for the treatment of oligoasthenoteratospermia | |
| PL1937245T3 (pl) | Związek użyteczny w zapobieganiu i leczeniu przerostu lewej komory u pacjentów dializowanych | |
| EP2193789A4 (en) | USE OF 3,5-DIHYDROTOLUENE OR ITS DERIVATIVES IN THE PREPARATION OF MEDICINAL PRODUCTS OR FUNCTIONAL FOOD FOR THE TREATMENT OR PREVENTION OF DEPRESSION | |
| MX2009005503A (es) | Uso de l-carnitina para la preparacion de un medicamento en forma de gotas oculares para el tratamiento de enfermedades de la cornea. | |
| IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
| WO2005049483A3 (de) | Reaktive chlorverbindungen, deren derivate, anionen und salze sowie verfahren zu deren herstellung und verwendung | |
| GB0313386D0 (en) | Treatment of disease | |
| WO2006117624A3 (en) | Kynurenic acid and salts thereof for the prevention and treatment of shock | |
| HK1135030A1 (en) | Composition useful for the treatment of type 2 diabetes | |
| DE60222662D1 (de) | Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung | |
| WO2005060978A3 (en) | Polymetaphosphate based formulations for therapy of microcrystalline arthropathies | |
| SI1824472T1 (sl) | Uporaba acetil-l-karnitina za zdravljenje fibromialgiäśnega sindroma | |
| WO2008034895A3 (en) | Ansamycin derivatives |